CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 433 enrolled
Drug / intervention
to estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVDother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05612217
NCT05612217N/ACompleted
CompareCT.gov

A Study to Evaluate a Accuracy of the AIVARIX AI-based Application in Detecting Signs C 1-2 Classes of CVD in Outpatients Seeking Consultancy of Phlebologists in the Russian Federation

Servier Russia·observational·Posted Nov 10, 2022·Updated Sep 25, 2024

In Brief

An observational study evaluating to estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVD for Chronic Venous Disease and CVD. Completed, enrolled 433 participants across 1 site.

Detailed Summary

This study is a multicenter observational study, which is carried out in frame of routine clinical practice in Russia. The program will include patients suggestive to chronic venous diseases (CVDs) including but not limited to those with C1 and C2 classes by CEAP classification, who will be seeking professional phlebologists' consultation. Study conduction is scheduled in Russia in 2022-2023. The planned number of patients is 414

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Venous Disease, CVD
CountriesRussia
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedNov 10, 2022
Enrollment StartDec 1, 2022
Primary CompletionJun 1, 2023
Study CompletionApr 1, 2024
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.6 years ago

Interventions

to estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVDother

to estimate Sensitivity and Specificity of the AI-based AIVARIX app in detecting C1 and C2 classes of CVD in patients who are seeking for professional advice from a phlebologist regarding symptoms and signs suggestive to CVD.